Prediction of cord blood leptin on infant’s neurodevelopment: A birth cohort in rural Yunnan, China

Abstract

BackgroundLeptin, one of the peptide hormones secreted by adipocytes, plays a vital part in metabolism, but its role in early-life neurodevelopment remains poorly understood. MethodsWe performed leptin analysis on 323 cord blood samples collected from a birth cohort in Yunnan rural area, China, and assessed infants’ neurodevelopment at one year of age by the Bayley Scales of Infant and Toddler Development-Third Edition (BSID-III). Multiple linear regression and binary logistic regression models were used to explore the associations between cord blood leptin (CBL) concentrations and infants’ neurodevelopment and the ability of CBL to predict the probabilities of infants’ neurodevelopment delay. ResultsOverall, 323 infants were included in this study. The median concentration of CBL was 4.7 ng/ml. The proportion of 1-year-old infants identified as being neurodevelopmental delayed was 34.5%, and delays in cognitive, language, and motor domains were 11.1%, 26.6%, and 13.9%, respectively. Multiple linear regression analyses manifested that the CBL concentration (log10-transformed) was positively correlated with the cognitive, language, and motor composite scores in infants, respectively (β = 7.76, 95%CI: 3.81–11.71; β = 6.73, 95%CI: 3.41–10.06; and β = 6.88, 95%CI: 3.48–10.29, respectively). Binary logistic regression analysis showed that compared with the higher, lower CBL (< 4.7 ng/ml) yielded a 1.41-fold increase in the risk of language development delay (OR = 2.41，95%CI: 1.42–4.09), a 1.49-fold higher risk of motor development delay (OR = 2.49, 95%CI: 1.25–4.96), and a 1.71-fold higher risk of neurodevelopment delay (OR = 2.71, 95%CI: 1.64–4.48) among infants. The prediction models showed that the probabilities of development delay in infants’ language, motor, and neurodevelopment increased with the decline of CBL concentrations [rs = −0.63 (95% CI: −0.71, −0.56), rs = −0.46 (95% CI: −0.55, −0.38), rs = −0.55 (95% CI: −0.63, −0.46), respectively]. ConclusionThe decline of CBL was associated with the decrease in infants’ neurodevelopment scores at one year of age. CBL below 4.7 ng/ml may increase the risk of infants’ neurodevelopment delay. The probabilities of infants’ neurodevelopment delay increased with the decrease of CBL concentrations. CBL may be a predictor of the probability of children’s neurodevelopment delay.